The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy S. Lichtiger et al. Adalimumab safety and outcomes in Crohn's patients who failed infliximab

Autor: Lichtiger, S.1 (AUTHOR), Binion, D. G.2 (AUTHOR), Wolf, D. C.3 (AUTHOR), Present, D. H.1 (AUTHOR), Bensimon, A. G.4 (AUTHOR), Wu, E.4 (AUTHOR), Yu, A. P.4 (AUTHOR), Cardoso, A. T.5 (AUTHOR), Chao, J.5 (AUTHOR), Mulani, P. M.5 (AUTHOR), Lomax, K. G.5 (AUTHOR), Kent, J. D.5 (AUTHOR)
Zdroj: Alimentary Pharmacology & Therapeutics. Nov2010, Vol. 32 Issue 10, p1228-1239. 12p. 4 Charts, 2 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje